Research reports published in the Journal of Cancer Epidemiology, Biomarkers, and Prevention show that there is a negative correlation between circulating 25-hydroxyvitamin D [25 (OH) D] levels and liver cancer risk and chronic liver disease mortality To associate. Gabriel Y. Lai, author of the Department of Cancer Control and Population Science at the National Cancer Institute, and colleagues say that there has been a link between reduced vitamin D levels and chronic liver disease and gomarara rechiropa observed in laboratory studies, but there has been little epidemiology Research assesses these associations.
Chidzidzo ichi chaisanganisira 854 varume vekuFinnish vanoputa vakapinda mualpha-tocopherol, beta-carotene zvidzidzo zvekudzivirira kenza uye akayera vhitamini D mazinga kubva muserum samples. Mukati memakore anoda kusvika 25 ekutevera, varwere ve202 vakaonekwa vaine kenza yechiropa uye varwere ve225 vakafa nechirwere chechiropa. 427 zvidzidzo zvisina chirwere chechiropa kana kenza yechiropa yakashanda sekutonga. Pakati pezvidzidzo zvine serum 25 (OH) D yekumisikidza isingasviki gumi ng / mL (ng / mL), njodzi yekenza yechiropa yakawedzera ne10% kana ichienzaniswa neavo vane huwandu hwekusungwa hwakakura kupfuura 91 ng / mL, chisingaperi Njodzi. yekufa kwechirwere chechiropa yakawedzera ne20%.
"Zvigumisiro zvedu zvinoratidza kuti vitamini D inogona kuva nekudzivirira kwekenza yechiropa uye chirwere chisingaperi chechiropa," Dr. Lai nevamwe vaaishanda navo vakapedzisa. "Zvidzidzo zvenguva yemberi zvinoda kuongorora hukama pakati pevhitamini D nekenza yechiropa uye chirwere chechiropa mune vamwe vanhu, kunyanya avo vane Njodzi dzakasiyana."
